These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8254341)

  • 1. New platinum(II) complexes of beta-cyclodextrin diamine derivatives and their antitumor activity.
    Cucinotta V; Mangano A; Nobile G; Santoro AM; Vecchio G
    J Inorg Biochem; 1993 Nov; 52(3):183-90. PubMed ID: 8254341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and antitumor activity of new chloroethylamine platinum complexes.
    Khokhar AR; Xu Q; Newman RA; Kido Y; Siddik ZH
    J Inorg Biochem; 1992 Feb; 45(3):211-9. PubMed ID: 1634893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of (diamine)platinum(II) complexes of benzylmalonate derivatives.
    Lee YA; Chung YK; Sohn YS
    J Inorg Biochem; 1997 Dec; 68(4):289-94. PubMed ID: 9397577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
    Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
    Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro cytotoxicity of lipophilic platinum(II) complexes.
    Kokotos G; Theodorou V; Constantinou-Kokotou V; Gibbons WA; Roussakis C
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1525-30. PubMed ID: 9873383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inclusion compound of a new ionizable derivative of beta-cyclodextrin with ferrocenium drug.
    Lu CS; Ren XM; Hu CJ; Zhu HZ; Meng QJ
    Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):818-21. PubMed ID: 11456085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
    Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
    Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum complexes of diaminocarboxylic acids and their ethyl ester derivatives: the effect of the chelate ring size on antitumor activity and interactions with GMP and DNA.
    Moradell S; Lorenzo J; Rovira A; Robillard MS; Avilés FX; Moreno V; de Llorens R; Martinez MA; Reedijk J; Llobet A
    J Inorg Biochem; 2003 Sep; 96(4):493-502. PubMed ID: 13678816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual dimeric chemical structure for a carboplatin analogue as a potential anticancer complex.
    Xie M; Liu W; Lou L; Chen X; Ye Q; Yu Y; Chang Q; Hou S
    Inorg Chem; 2010 Jul; 49(13):5792-4. PubMed ID: 20515022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor inhibiting [1,2-bis(difluorophenyl)ethylenediamine]dichloroplatinum (II) complexes, I: Synthesis.
    Müller R; Schickaneder E; Jennerwein M; Reile H; Spruss T; Engel J; Schönenberger H
    Arch Pharm (Weinheim); 1991 Feb; 324(2):115-20. PubMed ID: 1854235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
    Han I; Khokhar AR; Perez-Soler R
    Cancer Chemother Pharmacol; 1996; 39(1-2):17-24. PubMed ID: 8995495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
    Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro antitumor activity of oligonucleotide-tethered and related platinum complexes.
    Cai L; Lim K; Ren S; Cadena RS; Beck WT
    J Med Chem; 2001 Aug; 44(18):2959-65. PubMed ID: 11520204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin Rotaxanes of Pt Complexes and Their Conversion to Pt Nanoparticles.
    Suzaki Y; Fujii Y; Osakada K
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33260384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity studies on leaving group derivatives of [meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] platinum(II).
    Gust R; Keilitz R; Krauser R; Schmidt K; Schnurr B
    Arch Pharm (Weinheim); 1999 Aug; 332(8):261-70. PubMed ID: 10489536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.